홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
KPRX
#4864
Kiora Pharmaceuticals, Inc. Common Stock
2.440
0
USD
+1.67%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+1.67%
월간 변동
+15.64%
6달 변화
+16.19%
년간 변동율
+16.19%
이전 종가
2.400
0
Open
2.440
0
Bid
Ask
Low
2.440
0
High
2.440
0
양
1
마켓
주식
헬스케어
KPRX
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
19.72 K
35.18 K
213.25 K
2.92 M
3 M
3.95 M
—
Valuation ratios
Enterprise value
—
11.76 M
541.77 K
12.32 M
6.11 M
-913.83 K
18.05 M
Price to earnings ratio
—
-0.85
-0.18
-0.21
3.79
-0.75
-3.85
Price to sales ratio
—
—
-171.23
106.85
0.85
—
—
Price to cash flow ratio
—
-1.28
-0.24
-0.29
1.59
-0.81
-5.07
Price to book ratio
—
1.51
0.22
0.45
0.53
0.5
0.85
EBITDA 비율에 대한 기업 가치
—
-0.67
-0.04
-0.99
1.35
0.07
-1.82
Profitability ratios
Return on assets %
-0.53
-0.91
-0.73
-0.91
0.1
-0.45
-0.4
Return on equity %
-1.16
-1.78
-1.19
-2.05
0.14
-0.67
-0.59
Return on invested capital %
-341.5
-589.26
-473.82
-481.82
131.65
-799.53
-618.8
Gross margin %
100
—
100
100
100
—
—
Operating margin %
-68.1 K
—
84.9 K
-49.35 K
28.15
—
—
EBITDA margin %
-67.83 K
—
84.72 K
-49.05 K
28.27
—
—
Net margin %
-67.1 K
—
93.69 K
-49.07 K
22.44
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
1.02
5.59
2.35
2.9
4.94
5.99
27.69
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0
0
-0
0
0.64
0
0
Solvency ratios
Debt to assets ratio
0.02
0.03
—
—
—
—
—
Debt to equity ratio
0.05
0.05
—
—
—
—
—
Long term debt to total assets ratio
0.02
0.02
—
—
—
—
—
Long term debt to total equity ratio
0.04
0.03
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
-424.17
-128.16
-17.76
2.07
-2.43
-2.42
EBIT per share
—
-660.06
-151.46
-23.35
1.09
-3.13
-3.12
EBITDA per share
—
-658.3
-150.95
-23.25
1.1
-3.12
-3.11
Total debt per share
—
19
—
—
—
—
—
Cash per share
—
306.01
73.3
4.56
6.49
4.16
19.5
Net current asset value per share
—
350.27
94.4
8.81
7.2
5.3
23.13
Tangible book value per share
—
20.6
8.17
-5.03
4.62
3.43
14.94
Working capital per share
—
287.56
54.18
5.77
5.74
4.41
19.61
Book value per share
—
359.38
140.2
11.36
6.24
3.93
20.23
뉴스
키오라 파마슈티컬, 자문위원회에 망막 전문의 추가
Kiora Pharmaceuticals adds retina specialist to advisory board
키오라 파마슈티컬스, KIO-100 제형 관련 신규 특허 취득
Kiora Pharmaceuticals receives new patent for KIO-100 formulations
키오라 제약, 3분기 실적 발표 및 망막 질환 임상 진전
Kiora Pharmaceuticals reports Q3 results, advances retinal disease trials
Kiora joins RARE-X Vision Consortium to advance rare eye disease research
Kiora pharma reports Q2 results, advances retinal disease trials
Vicarious Surgical appoints Stephen From as new CEO
Kiora Pharmaceuticals stock rises after receiving patent for KIO-104
Kiora Pharmaceuticals receives patent for ocular disease treatment
Kiora Pharmaceuticals (KPRX) Upgraded to Strong Buy: Here's What You Should Know